Celularity Annual Revenue, Competitors, Number of Employees and Funding

Claim your profile

Overview

Location:
Warren, NJ USA
Total Funding:$367.7M
Industry:Biotech
Founded:2016
Lead Investor(s):N/A
Press
Claim your profile

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Celularity's estimated annual revenue is currently $24M per year.
  • Celularity received $250.0M in venture funding in February 2018.
  • Celularity's estimated revenue per employee is $155,000
  • Celularity's total funding is $367.7M.

Employee Data

  • Celularity has 155 Employees.
  • Celularity grew their employee count by -1% last year.
  • Celularity currently has 3 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Hydromer
$8.8M57N/AN/A
SCYNEXIS
N/A43N/AN/A
Cellectar Biosc...
N/A19N/AN/A
Soligenix
N/A27N/AN/A
Gibraltar Labor...
$9M58N/AN/A
Apprentice.io
$4.5M29N/AN/A
AES CHEMUNEX
$3.4M22N/AN/A
GENEWIZ
$87.6M5653%N/A
Celsion Corpora...
N/A38N/AN/A
Hitachi Chemica...
$40.1M25913%N/A
Missing a competitor? Contribute!?
Submit

POSTPARTUM PLACENTA: THE FOUNDATION OF OUR SCIENCE - Celularity scientists were the first to recognize the human placenta as an untapped resource for innovation, one which is the basis of Celularity innovations in immuno-oncology, hematology, and regenerative medicine. Our seminal discovery of unique stem, progenitor, and immune cells from the placenta is the foundation of our dominating intellectual property position. With proprietary platform technology and operational expertise to harness the power of this remarkable organ, we developed a deep therapeutic pipeline across a broad range of indications. AMPLIFYING THE BODYS ABILITY TO REGENERATE - Celularity combines innovative assets and research in cell therapy, functional regeneration, and biosourcing to develop leading therapeutic products and services that treat serious, life-threatening diseases. We are harnessing the unique cells and biomaterials from the postpartum placenta to provide therapies that amplify the body's ability to fight disease, heal, and regenerate itself. For more information visit our website at www.celularity.com

keywords:N/A

155

Number of Employees

$24M

Revenue (est)

3

Current Jobs

-1%

Employee Growth %

$367.7M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Beth SteinbrennerExecutive Vice President, Human Resources Email Available
James EdingerSenior Director Integrative Research & StrategyEmail Available
Margot GriffithAssociate Director, Talent Acquisition Service & OperationsEmail Available
Stacy HerbSVP, Global Project LeaderEmail Available
Solveig EricsonVP Clinical Development
Joseph DosSantosVice President, Financial Analytics And StrategyEmail Available
Holly AdamskiProject Manager, Global ProjectsEmail Available
Mark HoffmanRegional Business ManagerEmail Available
Marco JimenezManager, Information TechnologyEmail Available
Sanjay SehgalSenior Vice President, Regulatory Affairs, Qa & Conformance

Celularity News

09/08/2019 - How Serial Entrepreneur Robert Hariri Is Revolutionizing Cell ...

A spinout of Celgene, Celularity made big news in February 2018, when it raised $250 million to accelerate development of its stem cell ...

03/29/2019 - Celularity Announces Results of Phase 1 Studies of PNK-007 ...

WARREN, N.J.--(BUSINESS WIRE)--Celularity, Inc. (“Celularity” or the “Company”), a clinical-stage cell therapeutics company developing ...

04/11/2019 - Celularity Enters Lease to Develop Advanced Cell ...

WARREN, N.J.--(BUSINESS WIRE)--Celularity, Inc. (“Celularity” or the “Company”), a clinical-stage cell therapeutics company developing ...

Celularity Funding

DateAmountRoundLead InvestorsReference
2018-02-16$250.0MUndisclosedMultipleArticle

Celularity Acquisitions

DateCompany NameAmountNotesReference
2018-09-04CariCordArticle